Overactive Bladder

Is there a correlation between urodynamics findings and clinical outcomes in females with idiopathic overactive bladder syndrome (OAB).

This study investigates the intricate relationship between urodynamic findings and clinical symptoms in females with overactive bladder (OAB).

A retrospective cohort study, conducted at a tertiary university hospital, included female patients with positive detrusor overactivity (DO) OAB between November 2020 and November 2023.

New insights into the association between arthritis and overactive bladder in NHANES 2005-2020.

Arthritis and overactive bladder (OAB) are both common diseases, but the association between them remains unclear. The aim of our research is to investigate the possible link with regard to arthritis and OAB.

Clinical efficacy of transcutaneous pelvic floor magnetic stimulation combined with urination training in the treatment of overactive bladder in children.

This study aimed to evaluate the clinical effect of transcutaneous pelvic floor magnetic stimulation combined with urination training in the treatment of overactive bladder (OAB) in children.

In this study, the clinical data of 42 children with OAB who were treated with transcutaneous pelvic floor magnetic stimulation combined with the urination training method at our hospital from March 2022 to December 2022 (Group B) were collected.

Global Prevalence of Overactive Bladder: A Systematic Review and Meta-analysis.

This study aims to systematically estimate the global prevalence of overactive bladder (OAB), identify demographic and regional factors contributing to prevalence variations, and assess trends in prevalence over the past two decades.

Health utility value of overactive bladder in Japanese older adults.

To determine the health utility values (HUVs) of overactive bladder (OAB), defined as urinary urgency, usually accompanied by urinary daytime or nocturnal frequency, with or without urinary incontinence, among adults aged ≥65 years and to assess the HUV decrements (disutilities) of OAB according to its severity.

Up-and-coming pharmacotherapeutic options for treating patients with refractory overactive bladder.

Overactive bladder (OAB) is a prevalent disorder with a significant impact on quality of life. The pathophysiology of OAB is multifactorial and the majority of patients will require treatment with multiple therapies across the course of their disease.

Can Baseline Urodynamic Findings Predict the Outcomes and Complications of Intravesical Injections of Onabotulinum Toxin A for Overactive Bladder?

Intravesical Onabotulinum Toxin A (Botox A) injections are an established minimally invasive therapy option for the treatment of refractory overactive bladder (OAB) symptoms in adults. We have assessed whether baseline urodynamic findings can predict self-reported patient outcomes and posttreatment voiding difficulties.

Exploring the Association Between Overactive Bladder (OAB) and Cognitive decline: mediation by depression in elderly adults,   a NHANES weighted analysis.

Overactive bladder (OAB) is a prevalent condition among older adults and may be linked to cognitive health. This study explored a relationship between OAB and cognitive health among adults aged 60 ≥ years in the United States, using NHANES 2011-2014.

Efficacy of 100-U Onabotulinumtoxin A Treatment in Female Idiopathic Overactive Bladder-A Prospective Follow-Up Study.

Overactive bladder (OAB) affects 11-17% of the female population. First-line treatment with lifestyle modifications and second-line therapy with medications are often limited by inadequate efficacy or pharmacological side effects.

Increased Afferent Nerve Firing Is Correlated With the Detection of Bladder Wall Micromotion in a Perfused Ex-Vivo Porcine Model.

Observable autonomous rhythmic changes in intravesical pressure, termed bladder wall micromotion, is a phenomenon that has been linked to urinary urgency, the key symptom in overactive bladder (OAB).